The 52-year-old executive sitting across from me had normal testosterone on paper. His cardiologist cleared him. His primary care physician suggested Viagra and sent him on his way. Yet here he was, six months later, still struggling with erectile function that had steadily declined over two years—and now beginning to question whether this was just inevitable aging or something his doctors were missing.
He was right to question it. Most patients with erectile dysfunction never receive a true root cause workup. They receive a prescription.
What Conventional Medicine Misses About Erectile Dysfunction
The standard approach to ED treats it as a hydraulic failure—inadequate blood flow that can be temporarily corrected with a PDE5 inhibitor. Take the pill, improve the flow, problem solved. Except for the growing number of men for whom the pills stop working, never worked well to begin with, or only mask a deeper physiological decline.
What gets overlooked is that erectile function is a vascular event, a hormonal event, a neurologic event, and a metabolic event occurring simultaneously. When any of those systems degrade, function suffers. The 2024 update to the StatPearls clinical review on erectile dysfunction makes this clear: ED prevalence escalates with age not because aging itself causes dysfunction, but because the cumulative metabolic, vascular, and hormonal damage becomes clinically apparent.
Most men over 45 walking into a conventional urology office will leave with a Cialis prescription and no investigation into their fasting insulin, their free testosterone-to-estradiol ratio, their inflammatory markers, or their endothelial function. The symptom gets treated. The system remains broken.
The Science: Why Erectile Function Reflects Systemic Health
Erections require functional endothelium—the single-cell layer lining your blood vessels that produces nitric oxide, the molecule responsible for vasodilation. When endothelial cells become dysfunctional due to insulin resistance, chronic inflammation, or oxidative stress, nitric oxide production drops. The penile vasculature, with some of the smallest diameter arteries in the body, shows this dysfunction first.
This is why multiple longitudinal studies have demonstrated that erectile dysfunction often precedes coronary artery disease by three to five years. It is the same disease process, simply manifesting earlier in smaller vessels. A 2023 meta-analysis in the Journal of Sexual Medicine confirmed what regenerative physicians have long suspected: men with ED and no cardiac symptoms have significantly higher rates of subclinical atherosclerosis on imaging compared to age-matched controls.
Hormonal optimization matters because testosterone is not just about libido. It modulates nitric oxide synthase expression, influences smooth muscle tone in the corpora cavernosa, and affects the sensitivity of tissues to phosphodiesterase inhibitors. Men with low-normal or suboptimal free testosterone often report that medications like Viagra work poorly—because the underlying androgen signaling is insufficient to support the downstream pathway.
Then there is the metabolic component. Insulin resistance damages the same endothelial cells that produce nitric oxide, creates a pro-inflammatory environment, and often coexists with visceral adiposity that aromatizes testosterone into estradiol. Most patients do not connect their ED with their expanding waistline or their rising fasting glucose, but the mechanisms are deeply intertwined.
A Composite Clinical Scenario
A 48-year-old attorney presented with progressive ED over 18 months. He could achieve partial erections but could not maintain them. His primary care physician had checked a total testosterone—it was 520 ng/dL, technically normal. He was given a trial of tadalafil, which helped modestly but inconsistently.
Comprehensive labs told a different story. Free testosterone was at the 22nd percentile for his age. Estradiol was elevated at 42 pg/mL. Fasting insulin was 14 mU/L, suggesting early insulin resistance. His HbA1c was 5.6%, pre-diabetic range. Lipid particle testing showed elevated small dense LDL. He had metabolic syndrome in its earliest, subclinical form—and his erectile dysfunction was the presenting symptom.
Most patients in this scenario respond well to a combination of metabolic correction, hormonal optimization, and targeted peptide therapy. Within eight weeks of starting testosterone optimization, metformin for insulin sensitization, and a trial of PT-141 peptide for central dopaminergic signaling, his function had improved considerably. Four months later, he no longer needed PDE5 inhibitors for reliable function.
The Arbour Longevity Approach to Erectile Dysfunction
We do not start with a prescription. We start with a diagnostic workup that includes comprehensive hormone panels—total and free testosterone, estradiol, SHBG, DHEA-S, prolactin—alongside metabolic markers like fasting insulin, HbA1c, lipid particle analysis, and inflammatory markers including high-sensitivity CRP.
For patients in Ann Arbor seeking more than symptom suppression, this approach identifies whether the primary driver is hormonal, metabolic, vascular, or some combination. That clarity changes the treatment strategy entirely.
Depending on what we find, treatment may include bioidentical hormone replacement tailored to achieve optimal free testosterone levels, peptide therapies like PT-141 for neurologic signaling or BPC-157 for tissue repair, and the P-Shot—platelet-rich plasma injections that deliver growth factors directly to penile tissue to support endothelial repair and neovascularization.
We also address the metabolic foundation. Weight loss protocols using GLP-1 receptor agonists can rapidly improve insulin sensitivity and reduce systemic inflammation. NAD+ IV therapy supports mitochondrial function and may improve endothelial health. These are not alternative treatments—they are physiologic interventions targeting the mechanisms underlying dysfunction.
What to Expect During Your Consultation
The initial consultation involves a detailed medical and sexual health history, a physical exam, and ordering labs if recent comprehensive panels are not available. Most patients appreciate that we spend time understanding the timeline of symptoms, the context of stress or metabolic change, and the prior treatments attempted.
Lab results typically return within one week. The follow-up visit reviews findings in detail and outlines a treatment plan personalized to your physiology—not a protocol pulled from a flowchart. Most patients begin to notice subjective improvement within four to eight weeks, with continued optimization over three to six months as hormonal and metabolic variables stabilize.
The goal is restoration of function without indefinite dependence on symptomatic medications, though we recognize some patients will benefit from combining optimized physiology with targeted pharmaceutical support.
What is the main cause of erectile dysfunction in men over 40
There is rarely a single cause. Most cases in men over 40 involve a combination of vascular endothelial dysfunction, suboptimal androgen levels, and metabolic factors like insulin resistance or visceral adiposity. The penile arteries are among the smallest in the body, so systemic vascular disease manifests there first. Psychological factors can coexist but are seldom the primary driver in this age group.
How does testosterone affect erectile dysfunction
Testosterone influences erectile function through multiple pathways: it upregulates nitric oxide synthase in endothelial cells, supports the structural integrity of smooth muscle in the corpora cavernosa, and modulates central libido and arousal. Men with low or low-normal free testosterone often report diminished response to PDE5 inhibitors because the underlying signaling architecture is impaired. Optimizing testosterone frequently restores medication efficacy or reduces the need for it entirely.
Can peptide therapy help with erectile dysfunction
Certain peptides show clinical promise. PT-141 (bremelanotide) works centrally through melanocortin receptors to enhance sexual arousal and has been studied in both men and women. BPC-157 may support vascular and tissue repair. These are used adjunctively in patients who have incomplete responses to hormonal optimization or who want to avoid chronic PDE5 inhibitor use. Response varies, but most patients tolerate peptides well with minimal side effects.
What is the P-Shot and does it work for ED
The P-Shot involves injecting platelet-rich plasma—concentrated growth factors derived from your own blood—directly into penile tissue. The theory is that these growth factors stimulate angiogenesis, collagen remodeling, and tissue regeneration. Clinical data remains limited but growing, with several studies showing modest improvements in erectile function scores and patient satisfaction. Most patients see optimal results when the P-Shot is combined with systemic optimization of hormones and metabolism rather than used in isolation.
How long does it take to see results from ED treatment
Timeline depends on the underlying cause and the intervention. Hormonal optimization typically produces subjective improvements within four to eight weeks as testosterone levels stabilize. Peptide therapy may work within days to weeks depending on the compound. The P-Shot often requires six to twelve weeks for tissue remodeling to occur. Metabolic interventions like weight loss or insulin sensitization show progressive benefit over three to six months. Most patients notice meaningful change within the first two months.
Is erectile dysfunction a sign of heart disease
Often, yes. Erectile dysfunction and coronary artery disease share the same pathophysiology—endothelial dysfunction and atherosclerosis. Because the penile arteries are smaller, they show symptoms earlier. Multiple studies demonstrate that men with ED and no cardiac symptoms have higher rates of subclinical coronary disease on imaging. ED should be considered a window into vascular health, not just a sexual health issue. This is why comprehensive evaluation matters.
How much does erectile dysfunction treatment cost in Michigan
Cost varies widely depending on the treatment plan. A consultation at Arbour Longevity is $35, applied toward any treatment you pursue. Hormone therapy, peptide protocols, and procedures like the P-Shot are priced individually based on your personalized plan. We provide transparent cost estimates during your follow-up visit once we have reviewed your labs and discussed options. Most patients find the investment worthwhile given the systemic benefits that extend well beyond sexual function.
If This Sounds Familiar
If you have been told your levels are normal, that this is just aging, or that a pill is your only option—and you suspect there is more to the story—we would welcome the opportunity to take a deeper look. Arbour Longevity is located in Ann Arbor, Michigan, and our approach is built around identifying and correcting root causes, not simply managing symptoms.
Your initial consultation is $35, applied toward treatment if you decide to move forward. You can book online at arbourlongevity.com or call our team directly at 734-436-3357. We will spend the time necessary to understand what is happening and to build a plan that makes physiologic sense for you.
Leave a Reply